Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

Antiviral activity of lambda-carrageenan against influenza viruses

Global seaweed farming and processing in the past 20 years

Small molecules in the treatment of COVID-19

Nasal sprays for treating COVID-19: a scientific note

Full article: Sulphated polysaccharides from seaweeds as potential

Nutraceuticals, Free Full-Text

Antioxidants, Free Full-Text

Carrageenan - an overview

Full article: Can algae contribute to the war with Covid-19?

Marine bioactive compounds against SARS-CoV-2